|
2018 Journal Article Acetylsalicylic acid governs the effect of sorafenib in RAS- mutant cancersHammerlindl, Heinz, Ravindran Menon, Dinoop, Hammerlindl, Sabrina, Emran, Abdullah Al, Torrano, Joachim, Sproesser, Katrin, Thakkar, Divya, Xiao, Min, Atkinson, Victoria G., Gabrielli, Brian, Haass, Nikolas K., Herlyn, Meenhard, Krepler, Clemens and Schaider, Helmut (2018). Acetylsalicylic acid governs the effect of sorafenib in RAS- mutant cancers. Clinical Cancer Research, 24 (5), 1090-1102. doi: 10.1158/1078-0432.CCR-16-2118 |
|
2017 Journal Article Dendritic mesoporous silica nanoparticles for pH-stimuli-responsive drug delivery of TNF-alphaKienzle, Arne, Kurch, Sven, Schloder, Janine, Berges, Carsten, Ose, Robert, Schupp, Jonathan, Tuettenberg, Andrea, Weiss, Henning, Schultze, Jennifer, Winzen, Svenja, Schinnerer, Meike, Koynov, Kaloian, Mezger, Markus, Haass, Nikolas K., Tremel, Wolfgang and Jonuleit, Helmut (2017). Dendritic mesoporous silica nanoparticles for pH-stimuli-responsive drug delivery of TNF-alpha. Advanced Healthcare Materials, 6 (13) 1700012, 1700012+. doi: 10.1002/adhm.201700012 |
|
2017 Journal Article Targeting endothelin receptor signalling overcomes heterogeneity driven therapy failureSmith, Michael P., Rowling, Emily J., Miskolczi, Zsofia, Ferguson, Jennifer, Spoerri, Loredana, Haass, Nikolas K., Sloss, Olivia, Mcentegart, Sophie, Arozarena, Imanol, von Kriegsheim, Alex, Rodriguez, Javier, Brunton, Holly, Kmarashev, Jivko, Levesque, Mitchell P., Dummer, Reinhard, Frederick, Dennie T., Andrews, Miles C., Cooper, Zachary A., Flaherty, Keith T., Wargo, Jennifer A. and Wellbrock, Claudia (2017). Targeting endothelin receptor signalling overcomes heterogeneity driven therapy failure. EMBO Molecular Medicine, 9 (8), 1011-1029. doi: 10.15252/emmm.201607156 |
|
2017 Journal Article Cell cycle-tailored targeting of metastatic melanoma: challenges and opportunitiesHaass, Nikolas K. and Gabrielli, Brian (2017). Cell cycle-tailored targeting of metastatic melanoma: challenges and opportunities. Experimental Dermatology, 26 (7), 649-655. doi: 10.1111/exd.13303 |
|
2017 Journal Article NFIB mediates BRN2 driven melanoma cell migration and invasion through regulation of EZH2 and MITFFane, Mitchell E., Chhabra, Yash, Hollingsworth, David E. J., Simmons, Jacinta L., Spoerri, Loredana, Oh, Tae Gyu, Chauhan, Jagat, Chin, Toby, Harris, Lachlan, Harvey, Tracey J., Muscat, George E. O., Goding, Colin R., Sturm, Richard A., Haass, Nikolas K., Boyle, Glen M., Piper, Michael and Smith, Aaron G. (2017). NFIB mediates BRN2 driven melanoma cell migration and invasion through regulation of EZH2 and MITF. EBioMedicine, 16, 63-75. doi: 10.1016/j.ebiom.2017.01.013 |
|
2016 Journal Article JNK-ERK signalling in melanoma: rewired or entangled?Haass, N. K. (2016). JNK-ERK signalling in melanoma: rewired or entangled?. British Journal of Dermatology, 175 (6), 1139-1140. doi: 10.1111/bjd.14903 |
|
2016 Journal Article Multimodal tumor suppression by miR-302 cluster in melanoma and colon cancerMaadi, Hamid, Moshtaghian, Abdolvahab, Taha, Masoumeh Fakhr, Mowla, Seyed Javad, Kazeroonian, Asiye, Haass, Nikolas K. and Javeri, Arash (2016). Multimodal tumor suppression by miR-302 cluster in melanoma and colon cancer. International Journal of Biochemistry and Cell Biology, 81 (A), 121-132. doi: 10.1016/j.biocel.2016.11.004 |
|
2016 Journal Article Zielgerichtete Melanomtherapie – Die Rolle der dynamischen TumorheterogenitätHaass, Nikolas K. (2016). Zielgerichtete Melanomtherapie – Die Rolle der dynamischen Tumorheterogenität. Spectrum Dermatologie, 2016 (3), 14-17. |
|
2016 Journal Article Genome-wide gain-of-function screen for genes that induce epithelial-to-mesenchymal transition in breast cancerSkalamera, Dubravka, Dahmer-Heath, Mareike, Stevenson, Alexander J., Pinto, Cletus, Shah, Esha T., Daignault, Sheena M., Said, Nur Akmarina B. M., Davis, Melissa, Haass, Nikolas K., Williams, Elizabeth D., Hollier, Brett G., Thompson, Erik W., Gabrielli, Brian and Gonda, Thomas J. (2016). Genome-wide gain-of-function screen for genes that induce epithelial-to-mesenchymal transition in breast cancer. Oncotarget, 7 (38), 61000-61020. doi: 10.18632/oncotarget.11314 |
|
2016 Journal Article Cell cycle phase-specific drug resistance as an escape mechanism of melanoma cellsBeaumont, Kimberley A., Hill, David S., Daignault, Sheena M., Lui, Goldie Y. L., Sharp, Danae M., Gabrielli, Brian, Weninger, Wolfgang and Haass, Nikolas K. (2016). Cell cycle phase-specific drug resistance as an escape mechanism of melanoma cells. Journal of Investigative Dermatology, 136 (7), 1479-1489. doi: 10.1016/j.jid.2016.02.805 |
|
2016 Journal Article microRNA-7-5p inhibits melanoma cell proliferation and metastasis by suppressing RelA/NF-κBGiles, Keith M., Brown, Rikki A. M., Ganda, Clarissa, Podgorny, Melissa J., Candy, Patrick A., Wintle, Larissa C., Richardson, Kirsty L., Kalinowski, Felicity C., Stuart, Lisa M., Epis, Michael R., Haass, Nikolas K., Herlyn, Meenhard and Leedman, Peter J. (2016). microRNA-7-5p inhibits melanoma cell proliferation and metastasis by suppressing RelA/NF-κB. Oncotarget, 7 (22), 31663-31680. doi: 10.18632/oncotarget.9421 |
|
2016 Journal Article In vivo overexpression of Emi1 promotes chromosome instability and tumorigenesisVaidyanathan, Srividya, Cato, Kathleen, Tang, Lu, Pavey, Sandra, Haass, Nikolas K., Gabrielli, Brian G. and Duijf, Pascal H. G. (2016). In vivo overexpression of Emi1 promotes chromosome instability and tumorigenesis. Oncogene, 35 (41), 5446-5455. doi: 10.1038/onc.2016.94 |
|
2015 Journal Article Imaging- and flow cytometry-based analysis of cell position and the cell cycle in 3d melanoma spheroidsBeaumont, Kimberley A., Anfosso, Andrea, Ahmed, Farzana, Weninger, Wolfgang and Haass, Nikolas K. (2015). Imaging- and flow cytometry-based analysis of cell position and the cell cycle in 3d melanoma spheroids. Journal of Visualized Experiments, 106 (e53486) e53486, e53486. doi: 10.3791/53486 |
|
2015 Journal Article Short-term suppression of A315T mutant human TDP-43 expression improves functional deficits in a novel inducible transgenic mouse model of FTLD-TDP and ALSKe, Yazi D., van Hummel, Annika, Stevens, Claire H., Gladbach, Amadeus, Ippati, Stefania, Bi, Mian, Lee, Wei S., Kruger, Sarah, van der Hoven, Julia, Volkerling, Alexander, Bongers, Andre, Halliday, Glenda, Haass, Nikolas K., Kiernan, Matthew, Delerue, Fabien and Ittner, Lars M. (2015). Short-term suppression of A315T mutant human TDP-43 expression improves functional deficits in a novel inducible transgenic mouse model of FTLD-TDP and ALS. Acta Neuropathologica, 130 (5), 661-678. doi: 10.1007/s00401-015-1486-0 |
|
2015 Journal Article A stress-induced early innate response causes multidrug tolerance in melanomaRavindran Menon, D., Das, S., Krepler, C., Vultur, A., Rinner, B., Schauer, S., Kashofer, K., Wagner, K., Zhang, G., Bonyadi Rad, E., Haass, N. K., Soyer, H. P., Gabrielli, B., Somasundaram, R., Hoefler, G., Herlyn, M. and Schaider, H. (2015). A stress-induced early innate response causes multidrug tolerance in melanoma. Oncogene, 34 (34), 4448-4459. doi: 10.1038/onc.2014.372 |
|
2015 Journal Article Corrigendum: a stress-induced early innate response causes multidrug tolerance in melanoma (vol 34, pg 4448, 2015)Menon, D. Ravindran, Das, S., Krepler, C., Vultur, A., Rinner, B., Schauer, S., Kashofer, K., Wagner, K., Zhang, G., Rad, E. Bonyadi, Haass, N. K., Soyer, H. P., Gabrielli, B., Somasundaram, R., Hoefler, G., Herlyn, M. and Schaider, H. (2015). Corrigendum: a stress-induced early innate response causes multidrug tolerance in melanoma (vol 34, pg 4448, 2015). Oncogene, 34 (34), 4545-4545. doi: 10.1038/onc.2014.432 |
|
2015 Journal Article Dynamic tumor heterogeneity in melanoma therapy: how do we address this in a novel model system?Haass, Nikolas K. (2015). Dynamic tumor heterogeneity in melanoma therapy: how do we address this in a novel model system?. Melanoma Management, 2 (2), 93-95. doi: 10.2217/MMT.15.1 |
|
2015 Journal Article Friends or foes: IL-10 and TGF-beta in melanomaTikoo, Shweta and Haass, Nikolas K. (2015). Friends or foes: IL-10 and TGF-beta in melanoma. Experimental Dermatology, 24 (4), 254-255. doi: 10.1111/exd.12661 |
|
2015 Journal Article Expression of Bcl-xL and Mcl-1 in the Nonmelanoma Skin Cancers of Renal Transplant RecipientsBurke, Michael T., Morais, Christudas, Oliver, Kimberley A., Lambie, Duncan L. J., Gobe, Glenda C., Carroll, Robert P., Staatz, Christine E., Sinnya, Sudipta, Soyer, H. Peter, Winterford, Clay, Haass, Nikolas K., Campbell, Scott B. and Isbel, Nicole M. (2015). Expression of Bcl-xL and Mcl-1 in the Nonmelanoma Skin Cancers of Renal Transplant Recipients. American Journal of Clinical Pathology, 143 (4), 514-526. doi: 10.1309/AJCPQNB5WA3PLQBK |
|
2015 Journal Article Switching the sphingolipid rheostat in the treatment of diabetes and cancer comorbidity from a problem to an advantage.Haass, Nikolas K., Nassif, Najah and McGowan, Eileen M. (2015). Switching the sphingolipid rheostat in the treatment of diabetes and cancer comorbidity from a problem to an advantage.. BioMed Research International, 2015 165105, 165105.1-165105.9. doi: 10.1155/2015/165105 |
